Dr. Shengwen Wu​

Chairman

Ph.D. from Shanghai Institute of Organic Chemistry. Post-doctoral research at CNRS and NUS. More than 10 years in Senior Management roles in GSK, Tianjin pharmaceutical group and other Chinese companies. Broad experience in GMP plant management and operation. Founded Jiangxi LongLife Bio-Pharmaceutical in 2009 and served as CEO of Chiral Quest and general manager of Jiangxi LongLife from 2013. Chairman of Chiral Quest Group since 2020.​

CEO

Bachelor and master degree from Beijing University. Ph.D. from SUNY Stony Brook. Worked for Ren-Pharm International as technical manager, director, and Vice president. Completed 33 first filling projects, experience of more than 70 US ANDA fillings. Co-founded Suzhou Pengxu PharmaTech in 2011. Serves as CEO of Chiral Quest Group, after Suzhou Pengxu merged with Chiral Quest in 2020.

Dr. Peng Wang​

Dr. Pixu Li

CSO

Master degree from Beijing University. Ph.D. from University of Pennsylvania. Worked for Wyeth for 5 years as research scientist.  Associate professor at Soochow University. Published 29 papers and applied 122 patents (33 patents granted). Co-founded Suzhou Pengxu PharmaTech in 2011. Serves as CSO of Chiral Quest Group, after Suzhou Pengxu merged with Chiral Quest in 2020.

Dr. Wenge Li

VP of R&D

Ph.D. Institute of Chemistry, Chinese Academy of Sciences, Postdoctoral Fellow at Pennsylvania State University. Engaged in scientific research in internationally renowned laboratories, such as Hidemaso Takaya, Kyoto University, Nobel Prize winner D.H.R. Barton and Professor Xumu Zhang. More than 20 years of experience in asymmetric hydrogenation, chiral drug synthesis and 18 years of CDMO project management experience. Published more than 20 papers and patents. Currently serves as the Vice President of Research and Development at Chiral Quest Group.​​

Ph.D. from Imperial College London. More than 35 years pharmaceutical industry experience, in process chemistry and business development, with Merck, Parke Davis, Chirotech, DowPharma and Dr Reddy’s Laboratories. Currently serves as Senior Vice President for Global Business Development of Chiral Quest Group.

Senior Vice President Global Business Development

Dr. Ian Lennon